Latest news
InflaRx Reports Q2 2026 Results and Business Update, Advances Izicopan in AAV and Renal Diseases - Quiver QuantitativeQuiver Quantitative · Thu, 06 Aug 2026 11:44:00 GMTCadrenal Therapeutics Highlights CAD-1005 as Dual-Indication 12-LOX Inhibitor for HIT and CSA-AKI Following Competing Trial Failure - Quiver QuantitativeQuiver Quantitative · Mon, 03 Aug 2026 12:44:00 GMT